All In Biotech

Drug Trial Radar · NCT01623310

12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device

12-Month OL Evaluating the Safety of Intranasal Administration Fluticasone BID Using OptiNose Device in Subjects With CS With or Without Nasal Polyps

Last checked: Nov 19, 2026Latest source record: Jan 24, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

223

Actual

Start

Sep 2013

Primary completion

Aug 2015

Study completion Oct 2015

Sponsor

Lead sponsor
Optinose US Inc.Industry
Sponsor type
Industry
First posted
Jun 19, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, multicenter study designed to assess the safety of intranasal administration of 400 μg of fluticasone propionate twice a day delivered by the OptiNose device in subjects with chronic sinusitis with or without nasal polyps. The study consists of an up-to-7-day pretreatment phase followed a 12-month open-label treatment phase. The duration of each subject's participation is approximately 53 weeks.

Conditions

  • Nasal Polyps

Interventions

  • Fluticasone PropionateDrug

    Using Optinose Exhalation Delivery System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse EventsTime frame: 12 Months

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • Achieve Clinical Research

    Birmingham, Alabama

  • PAB Clinical Research

    Brandon, Florida

  • Sneeze Wheeze and Itch Associates

    Normal, Illinois

  • Professional Research Network of Kansas

    Wichita, Kansas

  • Best Clinical Trials

    New Orleans, Louisiana

  • PMG Research of Winston Salem

    Winston-Salem, North Carolina

  • HCCA Clinical Research Solutions

    Middleburg Heights, Ohio

  • Allergy and Asthma Research Group

    Eugene, Oregon

  • Clinical Research Solutions

    Franklin, Tennessee

  • William Blake Partners

    Grapevine, Texas

  • Focus Clinical Research

    Draper, Utah

  • InterMountain Ear Nose and Throat

    Salt Lake City, Utah

  • Advanced Clinical Research

    West Jordan, Utah

  • Premier Clinical Research

    Spokane, Washington

  • Exemplar Research

    Fairmont, West Virginia

  • Allergy Asthma and Sinus Center

    Greenfield, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.